title: Pioglitazone: European approval maintained despite the acknowledged risks.
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005602:France; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077205:Pioglitazone; D012306:Risk; D045162:Thiazolidinediones / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone